We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Accelerating Drug Discovery With Real-Time Kinetic and Affinity Analysis

Bioassays, such as the enzyme-linked bioabsorbant assay (ELISA), are standard techniques that require enzyme or fluorescent labels for the detection of target analytes. While these label-based studies give important information about a sample, such as binding affinity, they can only measure the interaction of an analyte at a given concentration and time, and are unable to gather kinetic analysis. Yet kinetic analysis is fundamental to many stages of the drug discovery and development pipeline, from lead development to complex biologics investigation.

Download this whitepaper to discover a method that can:

  • Reduce hit screening campaigns from weeks to days
  • Provide you with sensitive and rapid label-free analysis
  • Directly characterize antibodies from clinical blood plasma samples